AP NEWS

Global Clinical Trial Imaging Market Growth, Trends and Forecasts (2018-2023): Expected to Grow at a CAGR of 6.5% - ResearchAndMarkets.com

October 11, 2018

DUBLIN--(BUSINESS WIRE)--Oct 11, 2018--The “Global Clinical Trial Imaging Market - Segmented by Product and Service, Modality, End-User, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The Global Clinical Trial Imaging Market is expected to register a CAGR of nearly 6.5% during 2018-2023.

For most pharmaceutical and biotech companies, clinical development and non-clinical services costs account for 85% of R&D budget which can be reduced by using CROs.According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total R&D expenditure for pharmaceutical was around Euro 35,000 million. The high expenditure on R&D is indicating the novel drug discoveries. The advancements in the science and technology are augmenting the growth of pharmaceutical companies across the globe.With the rise in the number of pharmaceuticals companies, the pharmaceutical industry is entering into the new era of advanced medical development.The rise in the number of drug discoveries is augmenting the growth of clinical trials, the advancements in medical imaging technologies and rising adoption of the same across the globe is fuelling the demand for implementation of imaging technologies in clinical trials.The rise in the number of pharmaceutical and biotechnology companies is making it imperative for the manufacturers to deliver the best possible drug or medicine to the end user as competition is striking the companies. This factor is contributing to the rise of clinical trials as a large number of novel drug discoveries are being done by pharmaceutical and biotechnology companies.

Other factors which are driving market growth are the rise in number of contract research organizations and increase in research & development spending.

Key HighlightsGrowth in Pharmaceutical & Biotechnology CompaniesHigh Implementation Barriers & Costs of Imaging SystemsUS Leads the Market in North America

Major Market Developments

Intrinsic Imaging, LLC, has completed a very large 12,480 read pivotal oncology clinical trial

Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Company Profiles & Competitive Landscape

Bioclinica Inc.Biomedical Systems CorporationBiotelemetry Inc.Cardiovascular Imaging Technologies LLCIcon PLCIntrinsic Imaging LLCIxico PLCParexel International CorporationRadiant Sage LLCWorldcare Clinical LLC

For more information about this report visit https://www.researchandmarkets.com/research/6m8g95/global_clinical?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181011005454/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Clinical Trials

KEYWORD:

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/11/2018 09:00 AM/DISC: 10/11/2018 09:01 AM

http://www.businesswire.com/news/home/20181011005454/en

AP RADIO
Update hourly